News | Treatment Planning | November 24, 2015

Designation means The US Oncology Network will now offer RayStation to community-based oncology practices nationwide

RaySearch, RayStation, The US Oncology Network, radiation therapy, treatment planning systems, preferred provider

Image courtesy of RaySearch Laboratories


November 24, 2015 — RaySearch Laboratories AB announced that The US Oncology Network has selected RayStation to be offered throughout the network as one of the available radiation therapy treatment planning systems.

The US Oncology Network is one of America’s largest networks of integrated, community-based oncology practices, comprised of more than 350 sites and approximately 1,000 independent, community-based physicians who treat more than 800,000 patients annually. 90 sites are radiation oncology facilities and about 140 physicians specialize in radiation oncology. Many of the centers offer a complete array of treatments to give patients a continuity of care that is state-of-the-art, yet cost-effective. Physicians throughout the network collaborate and take part in programs to assure that they are optimizing treatment possibilities.

“We initiated an effort almost two years ago to assess treatment planning solutions being developed in the marketplace,” said Jeff Limmer, director of medical physics and quality, The US Oncology Network. “In this era of quickly emerging technologies, it is extremely important to continually assess projected capability, and then to plan, in both clinically and fiscally responsible ways, for the incorporation of tools and resources which provide high-quality care for patients. RayStation will be key in helping us achieve our goals.”

Radiation therapy departments in The US Oncology Network now have the opportunity to select RayStation as their treatment planning system. The first purchase made was at the Texas Center for Proton Therapy in June 2015.

For more information: www.usoncology.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now